As we close the second quarter of 2026, I find myself reflecting not just on what we’ve accomplished, but on what we’re becoming.
The dietary supplement industry has spent decades operating without a trusted, objective framework for measuring scientific credibility. Consumers are left navigating marketing claims, healthcare practitioners often lack transparent evaluation tools, and companies investing in science receive little differentiation for doing so.
At NutriSelect.ai, we’re building something fundamentally different.
Our vision has never been to create another supplement recommendation platform. It is to establish the world’s first Precision Supplement Intelligence™ Platform—a continuously learning intelligence infrastructure designed to transform scientific research into decision-grade intelligence.
Every milestone this quarter has strengthened that foundation.
Thank you for joining us on this journey.
— Dr. Bill Clark, PhD
Founder & CEO
This quarter marked one of the most significant periods of platform development since NutriSelect’s founding.
Rather than focusing solely on application features, our engineering and scientific efforts have centered on constructing the intelligence infrastructure that will power every future capability of the platform.
Recent milestones include continued advancement of the Precision Supplement Intelligence™ Engine, NScore™ Framework, Scientific Data Foundation, and Platform Intelligence Layer—all components of the NutriSelect Intelligence Stack™.
Together, these systems transform fragmented scientific information into structured, decision-grade intelligence capable of supporting consumers, practitioners, ingredient suppliers, product brands, enterprise organizations, and ultimately regulators.
This architecture represents far more than software. It is the foundation of a continuously learning intelligence ecosystem designed to improve as new scientific evidence and real-world outcomes become available.
Scientific integrity remains the cornerstone of every product decision at NutriSelect.
Throughout the quarter, we continued refining the methodologies that underpin the NScore™ scientific confidence framework, expanded evidence evaluation workflows, and further operationalized our structured approach to ingredient and product assessment.
Every enhancement is guided by a simple principle:
Scientific credibility should be measurable, transparent, and actionable.
Our Science Accelerator™ continues to take shape as the primary onboarding pathway into the NutriSelect ecosystem.
Designed for ingredient suppliers and product brands, the Accelerator helps organizations objectively measure scientific credibility, identify opportunities for improvement, and build evidence-based research roadmaps.
Beyond individual assessments, every participating organization contributes valuable intelligence that strengthens the entire platform.
This network effect represents one of NutriSelect’s most important long-term strategic advantages.
Innovation happens through collaboration.
During Q2, NutriSelect continued expanding relationships across the dietary supplement ecosystem, including ingredient suppliers, product brands, laboratories, clinical research organizations, scientific advisors, and strategic collaborators.
Each new partnership strengthens the platform’s intelligence foundation while helping advance a more transparent and evidence-based industry.
This quarter reinforced growing interest in evidence-based supplementation.
Highlights included publication of our Supplement Use & Perception Study, continued release of the AI Health Intelligence Brief, new thought leadership articles, podcast appearances, and ongoing engagement with industry leaders.
Collectively, these initiatives are helping establish NutriSelect as a trusted voice at the intersection of science, artificial intelligence, and nutritional innovation.
Interest in NutriSelect continues to expand globally.
Throughout the quarter, we engaged with prospective investors across North America, UK, Europe, Asia, Africa, and the Middle East who share our belief that scientific credibility will become an increasingly valuable strategic asset within the health and wellness industry.
Rather than pursuing capital alone, we’ve remained committed to identifying partners aligned with our long-term vision. Our Investor Protocols provide a structured framework for evaluating strategic fit, ensuring that future growth is supported by investors who value scientific integrity, responsible AI, and sustainable value creation.
As we continue to scale, we remain open to conversations with investors who share that vision.
Our priorities for the coming quarter remain clear:
Every dataset strengthens the platform.
Every assessment improves future intelligence.
Every partnership expands the ecosystem.
Together, these efforts move us closer to our mission of becoming the global intelligence standard for evidence-based supplementation.
Thank you for following our journey.
We look forward to sharing our continued progress next quarter.
